Celestica Inc. (CLS)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 424.15 |
|---|---|
| 52-week range | 330.79 – 655.50 |
| Return, 1 month / 3 months | −8.2% / +0.6% |
| Return, 1 year / 3 years | +7.8% / +1,098.8% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 77.4% |
| Worst drawdown (1 year) | -41.1% |
| Average daily value traded | 210.46M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Celestica is an electronics manufacturing services company based in Toronto, Canada. It designs, builds and supplies electronic products and components for original equipment manufacturers, handling everything from engineering and prototyping to volume production and after-market support. Its customers come from communications, enterprise computing, industrial, aerospace and defence, healthcare and consumer markets. Celestica operates manufacturing and design facilities in several countries and works closely with customers on supply chain and product lifecycle needs.
The shares are listed on the Toronto Exchange in Canada under the code CLS, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Celestica Inc. (CLS) trades on the Toronto Exchange in Canada. It last closed at CAD 424.15 on 19 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 546 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.8% and over the last three months it rose 0.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.4% | ||
| From 52-week high | -35.0% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.6% | ||
| 6-month return | -21.9% | ||
| 12-month return, skipping the last month | 17.4% | ||
| Stability (higher is calmer) | 24 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 77.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.1% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 210.46M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −17.9% |
|---|---|
| 1 month | −8.2% |
| 3 months | +0.6% |
| 6 months | −21.9% |
| 1 year | +7.8% |
| 3 years | +1,098.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 465.01 / 463.02 |
|---|---|
| Golden / death cross (60 days) | Golden, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 29.50 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.